Evidence map›Paper›PMID 33024916›Full record

ArticleHepatology communications2020

Functionally Diverse Inflammatory Responses in Peripheral and Liver Monocytes in Alcohol-Associated Hepatitis.

Adam Kim, Annette Bellar, Megan R McMullen, Xiaoxia Li, Laura E Nagy

Open access · goldAbstract read
In one paragraph

Article in Hepatology communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Therapeutics for Alcohol-Associated Liver Disease.Annual review of pharmacology and toxicology · 2026
    Review
  2. Article
  3. The Link between Alcohol Consumption and Kidney Injury.The American journal of pathology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Adam KimNorthern Ohio Alcohol Center Center for Liver Disease Research Department of Inflammation and Immunity Lerner Research Institute Cleveland Clinic Cleveland OH.ORCID https://orcid.org/0000-0002-3186-3912
Annette BellarNorthern Ohio Alcohol Center Center for Liver Disease Research Department of Inflammation and Immunity Lerner Research Institute Cleveland Clinic Cleveland OH.
Megan R McMullenNorthern Ohio Alcohol Center Center for Liver Disease Research Department of Inflammation and Immunity Lerner Research Institute Cleveland Clinic Cleveland OH.
Xiaoxia LiNorthern Ohio Alcohol Center Center for Liver Disease Research Department of Inflammation and Immunity Lerner Research Institute Cleveland Clinic Cleveland OH.
Laura E NagyNorthern Ohio Alcohol Center Center for Liver Disease Research Department of Inflammation and Immunity Lerner Research Institute Cleveland Clinic Cleveland OH.
Cleveland Clinic Lerner College of Medicine · US

Funding

Project Two - Exercise Training Decreases Alcohol Drinking by an FGF21-Dependent MechanismP50AA024333 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI LAURA E. NAGY · 2016 to 2026
$19.6M
IRAKM and Mincle in ALDR01AA023722 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI LI, XIAOXIA, NAGY, LAURA E. · 2015 to 2019
$2.2M
Novel therapeutics for alcoholic hepatitis - Cleveland Translational ComponentU01AA021890 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2012 to 2017
$1.6M
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repairU01AA026938 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2018 to 2023
$1.4M
C-Type Lectins and Immune Surveillance in ALDR00AA028048 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KIM, ADAM · 2022 to 2024
$892k
C-Type Lectins and Immune Surveillance in ALDK99AA028048 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI KIM, ADAM · 2019 to 2021
$308k
NIAAA NIH HHS K99 AA028048NIAAA NIH HHS P50 AA024333NIAAA NIH HHS R00 AA028048NIAAA NIH HHS R01 AA023722NIAAA NIH HHS U01 AA021890NIAAA NIH HHS U01 AA026938
6 · The paper itself

Abstract

Alcohol-associated hepatitis (AH) is an acute inflammatory disease in which gut-microbial byproducts enter circulation and peripheral immune cells infiltrate the liver, leading to nonresolving inflammation and injury. Single-cell RNA sequencing of peripheral blood mononuclear cells isolated from patients with AH and healthy controls paired with lipopolysaccharide (LPS) challenge revealed how diverse monocyte responses are divided among individual cells and change in disease. After LPS challenge, one monocyte subtype expressed pro-inflammatory genes in both disease and healthy controls, while another monocyte subtype was anti-inflammatory in healthy controls but switched to pro-inflammatory in AH. Numerous immune genes are clustered within genomic cassettes, including chemokines and C-type lectin receptors (CTRs). CTRs sense byproducts of diverse microbial and host origin. Single-cell data revealed correlated expression of genes within cassettes, thus further diversifying different monocyte responses to individual cells. Monocyte up-regulation of CTRs in response to LPS caused hypersensitivity to diverse microbial and host-derived byproducts, indicating a secondary immune surveillance pathway up-regulated in a subset of cells by a closely associated genomic cassette. Finally, expression of CTR genes was higher in livers of patients with severe AH, but not other chronic liver diseases, implicating secondary immune surveillance in nonresolving inflammation in severe AH.

Identifiers

PMID33024916
PMCPMC7527760
OpenAlexW3047256071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.